Related Experiment Video
Updated: Jun 27, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study
J Schmidt1, P Duhaut, A M Bourgeois
1Department of Internal Medicine, Place Victor Pauchet, Amiens University Hospital, 80000 Amiens CEDEX 1, France. schmidt.jean@chu-amiens.fr
Objectives:
An epidemic pattern has been reported for GCA and PMR. Immunological studies have shown that an unknown antigen activates the dendritic cells of the adventitia and the type 4 toll-like receptors. Procalcitonin (PCT) is an early marker of bacterial infection. The goal of the study was to assess the level of PCT in GCA and PMR at the onset of the disease.
Methods:
Patients diagnosed during the 2002-06 period were randomly selected. All the 46 patients fulfilled the ACR or the Hunder criteria, and all blood samples were taken before steroid therapy.
Results:
PCT was normal in all patients. PCT was slightly increased in men (0.087 +/- 0.023 microg/l) compared with women (0.066 +/- 0.027 microg/l) (P = 0.009), and in PMR (0.092 +/- 0.027 microg/l) compared with GCA (0.068 +/- 0.026 microg/l) (P = 0.018). There was no significant correlation with inflammation markers.
Conclusions:
These results are not in favour of a bacterial trigger for GCA or PMR. Increased PCT levels in patients with inflammatory syndrome, GCA-PMR symptoms and negative temporal artery biopsy may rule out the diagnosis of GCA and PMR.
Insights
Procalcitonin (PCT) levels were normal in patients with Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR), suggesting these conditions are not triggered by bacterial infections.
Area of Science:
- Rheumatology
- Immunology
- Infectious Disease
Background:
- Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) exhibit epidemic patterns.
- Immunological studies suggest activation of dendritic cells and toll-like receptors by an unknown antigen.
- Procalcitonin (PCT) is a known early marker for bacterial infections.
Purpose of the Study:
- To evaluate procalcitonin (PCT) levels in patients diagnosed with GCA and PMR at disease onset.
- To investigate the potential role of bacterial triggers in GCA and PMR pathogenesis.
Main Methods:
- A cohort of 46 patients diagnosed between 2002-2006 was randomly selected.
- All patients met established diagnostic criteria (ACR or Hunder).
- Blood samples were collected prior to the initiation of steroid therapy.
Main Results:
- Procalcitonin (PCT) levels were found to be normal in all GCA and PMR patients.
- Slightly elevated PCT levels were observed in men compared to women (P=0.009).
- PCT levels were higher in PMR patients compared to GCA patients (P=0.018), with no significant correlation to inflammation markers.
Conclusions:
- The findings do not support a bacterial trigger for GCA or PMR.
- Elevated PCT levels in patients with inflammatory syndromes and GCA/PMR symptoms, alongside a negative temporal artery biopsy, may help rule out GCA and PMR diagnoses.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Graves Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Graves' Disease I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
